Aveni Haynes
Senior Research Fellow
BA (Hons), MBBChir, MA (Cantab), PhD
aveni.haynes@health.wa.gov.au
https://www.linkedin.com/in/dr-aveni-haynes-79bb8193/Dr Aveni Haynes is a JDRF Post-doctoral Fellow and Senior Research Fellow based at The Kids Research Institute Australia, where she leads the epidemiology research theme in the Rio Tinto Children’s Diabetes Centre.
She has a strong research track record, establishing strong national and international collaborations, and demonstrating leadership capacity and roles in the field of childhood type 1 diabetes epidemiology, aetiology, and prevention research.
Dr Haynes is also an Investigator in the Australia-wide Environmental Determinants of Islet Autoimmunity (ENDIA) pregnancy early-childhood type 1 at risk cohort study which she also leads a sub-study to identify early changes in glucose levels using continuous glucose monitoring (CGM).
Her particular research interests include the aetiology and pathophysiology of childhood diabetes, with a focus on early life determinants and the developmental origins of health and disease. Current research focus is on informing type 1 diabetes prevention strategies by investigating early dysglycaemia in children at risk.
Projects
Using continuous glucose monitoring to detect early dysglycaemia in children participating in the ENDIA study (Sub Protocol)
Published research
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study
Dietary patterns characterised by high intakes of vegetables may lower the risk of pre-eclampsia and premature birth in the general population. The effect of dietary patterns in women with type 1 diabetes, who have an increased risk of complications in pregnancy, is not known.
Protocol for the Australian Type 1 Diabetes National Screening Pilot: Assessing the feasibility and acceptability of three general population screening models in children
One third of Australian children diagnosed with type 1 diabetes present with life-threatening diabetic ketoacidosis (DKA) at diagnosis. Screening for early-stage, presymptomatic type 1 diabetes, with ongoing follow-up, can substantially reduce this risk (<5% risk). Several screening models are being trialled internationally, without consensus on the optimal approach. This pilot study aims to assess three models for a routine, population-wide screening programme in Australia.
Environmental Determinants of Islet Autoimmunity (ENDIA) longitudinal prospective pregnancy to childhood cohort study of Australian children at risk of type 1 diabetes: parental demographics and birth information
The Environmental Determinants of Islet Autoimmunity Study is an ongoing Australian prospective cohort study investigating how modifiable prenatal and early-life exposures drive the development of islet autoimmunity and type 1 diabetes in children. In this profile, we describe the cohort's parental demographics, maternal and neonatal outcomes and human leukocyte antigen genotypes.
Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes
Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes, and technology use.
Education and Qualifications
- The University of Western Australia, PhD
- University of Cambridge Medical School, England, Bachelor of Medicine and Surgery (M.B., B.Chir.)
- University of Cambridge, Queens’ College, England, Bachelor of Medical Sciences (B.A. (Hons))
Awards/Honours
- The Kids Research Institute Australia, Illuminate Pitch - People’s Choice Award Winner
- Raine Medical Research Foundation, Strachan Memorial Prize - Best scientific paper arising from clinical research undertaken by an early-career researcher in Western Australia
Active Collaborations
- Co-Investigator: JDRF Global Centre of Excellence, International
- Co- Investigator: Environmental Determinants of Islet Autoimmunity (ENDIA) Study, National
- Co-Investigator: Australian T1D General Population Screening Pilot, National
- Co-Investigator: Australian T1D Immunotherapy Trials Collaborative